Cargando…

Statin as anti-cancer therapy in autochthonous T-lymphomas expressing stabilized gain-of-function mutant p53 proteins

An important component of missense mutant p53 gain-of-function (mutp53 GOF) activities is the ability of stabilized mutp53 proteins to upregulate the mevalonate pathway, providing a rationale for exploring the statin family of HMG-CoA reductase inhibitors as anticancer agents in mutp53 tumors. In th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tutuska, Karis, Parrilla-Monge, Laura, Di Cesare, Erica, Nemajerova, Alice, Moll, Ute M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7181693/ https://www.ncbi.nlm.nih.gov/pubmed/32332697 http://dx.doi.org/10.1038/s41419-020-2466-4

Ejemplares similares

Ganetespib synergizes with cyclophosphamide to improve survival of mice with autochthonous tumors in a mutant p53-dependent manner
por: Alexandrova, Evguenia M, et al.
Publicado: (2017)

p53 loss-of-heterozygosity is a necessary prerequisite for mutant p53 stabilization and gain-of-function in vivo
por: Alexandrova, Evguenia M, et al.
Publicado: (2017)

Gain-of-Function (GOF) Mutant p53 as Actionable Therapeutic Target
por: Schulz-Heddergott, Ramona, et al.
Publicado: (2018)

Depleting stabilized GOF mutant p53 proteins by inhibiting molecular folding chaperones: a new promise in cancer therapy
por: Alexandrova, Evguenia M, et al.
Publicado: (2017)

Regulation of miRNAs Expression by Mutant p53 Gain of Function in Cancer
por: Madrigal, Tzitzijanik, et al.
Publicado: (2021)

The Gain-of-Function p53 R248W Mutant Promotes Migration by STAT3 Deregulation in Human Pancreatic Cancer Cells
por: Klemke, Luisa, et al.
Publicado: (2021)

Non-oncogenic roles of TAp73: from multiciliogenesis to metabolism
por: Nemajerova, Alice, et al.
Publicado: (2018)

Regulators of Oncogenic Mutant TP53 Gain of Function
por: Yamamoto, Satomi, et al.
Publicado: (2018)

Gain-of-function mutant p53: history and speculation
por: Bargonetti, Jill, et al.
Publicado: (2019)

Mutant p53, the Mevalonate Pathway and the Tumor Microenvironment Regulate Tumor Response to Statin Therapy
por: Pereira, Madison, et al.
Publicado: (2022)

TAp73 is essential for germ cell adhesion and maturation in testis
por: Holembowski, Lena, et al.
Publicado: (2014)

Improving survival by exploiting tumor dependence on stabilized mutant p53 for treatment
por: Alexandrova, EM, et al.
Publicado: (2015)

Oncogenomic Approaches in Exploring Gain of Function of Mutant p53
por: Donzelli, Sara, et al.
Publicado: (2008)

Selective targeting of p53 gain-of-function mutants in cancer
por: Padmanabhan, Achuth
Publicado: (2018)

Gain-of-function mutant p53 in cancer progression and therapy
por: Zhang, Cen, et al.
Publicado: (2020)

Cancer-derived p53 mutants suppress p53-target gene expression—potential mechanism for gain of function of mutant p53
por: Vikhanskaya, Faina, et al.
Publicado: (2007)

Gain of function of mutant p53: R282W on the peak?
por: Zhang, Y, et al.
Publicado: (2016)

Context is everything: extrinsic signalling and gain-of-function p53 mutants
por: Amelio, Ivano, et al.
Publicado: (2020)

Gain-of-Function Mutant p53: All the Roads Lead to Tumorigenesis
por: Stein, Yan, et al.
Publicado: (2019)

Smad4 and p53 synergize in suppressing autochthonous intestinal cancer
por: Park, Jun Won, et al.
Publicado: (2022)

Editor's Note on ‘Cancer-derived p53 mutants suppress p53-target gene expression—potential mechanism for gain of function of mutant p53’
Publicado: (2023)

A novel mutant p53 binding partner BAG5 stabilizes mutant p53 and promotes mutant p53 GOFs in tumorigenesis
por: Yue, Xuetian, et al.
Publicado: (2016)

Cytoplasmic gain-of-function mutant p53 contributes to inflammation-associated cancer
por: Bellazzo, Arianna, et al.
Publicado: (2015)

Oncogenic Gain of Function in Glioblastoma Is Linked to Mutant p53 Amyloid Oligomers
por: Pedrote, Murilo M., et al.
Publicado: (2020)

Acquisition of aneuploidy drives mutant p53-associated gain-of-function phenotypes
por: Redman-Rivera, Lindsay N., et al.
Publicado: (2021)

P53 Gain-of-Function Mutants and Steroids in Ovarian Cancer Cell Metastasis
por: Candelaria, Nicholes, et al.
Publicado: (2021)

Differential chromatin accessibility landscape of gain-of-function mutant p53 tumours
por: Dhaka, Bhavya, et al.
Publicado: (2021)

Gain of Function (GOF) Mutant p53 in Cancer—Current Therapeutic Approaches
por: Roszkowska, Katarzyna A., et al.
Publicado: (2022)

Impairment of rigidity sensing caused by mutant TP53 gain of function in osteosarcoma
por: Luo, Ming, et al.
Publicado: (2023)

Therapeutic effects of statins against lung adenocarcinoma via p53 mutant-mediated apoptosis
por: Chou, Cheng-Wei, et al.
Publicado: (2019)

Targeting mutant p53 stabilization for cancer therapy
por: Wang, Jiajian, et al.
Publicado: (2023)

Regulation of Nucleotide Metabolism by Mutant p53 Contributes to its Gain-of-Function Activities
por: Kollareddy, Madhusudhan, et al.
Publicado: (2015)

Control of Nucleotide Metabolism Enables Mutant p53’s Oncogenic Gain-of-Function Activity
por: Schmidt, Valentina, et al.
Publicado: (2017)

Mutant p53 Gain-of-Function: Role in Cancer Development, Progression, and Therapeutic Approaches
por: Alvarado-Ortiz, Eduardo, et al.
Publicado: (2021)

The Gain of Function of p53 Mutant p53S in Promoting Tumorigenesis by Cross-talking with H-RasV12
por: Jia, Shuting, et al.
Publicado: (2012)

Direct reprogramming en route to neoplastic transformation
por: Nemajerova, Alice, et al.
Publicado: (2013)

Mutant TP53 driving the Warburg Effect in Mantle Cell lymphoma
por: Kliebhan, Johannes, et al.
Publicado: (2022)

Wild-type p53 oligomerizes more efficiently than p53 hot-spot mutants and overcomes mutant p53 gain-of-function via a “dominant-positive” mechanism
por: Walerych, Dawid, et al.
Publicado: (2018)

Spliced MDM2 isoforms promote mutant p53 accumulation and gain-of-function in tumorigenesis
por: Zheng, Tongsen, et al.
Publicado: (2013)

Allele-specific silencing of mutant p53 attenuates dominant-negative and gain-of-function activities
por: Iyer, Swathi V., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_sobdf8l07qu3u6hsija68ra9sa